Effects of metformin on endometrial cancer cell growth in vivo: a preoperative prospective trial. [electronic resource]
Producer: 20141107Description: 2986-95 p. digitalISSN:- 1097-0142
- AMP-Activated Protein Kinases -- metabolism
- Adult
- Aged
- Antigens, Neoplasm -- metabolism
- Antineoplastic Agents -- therapeutic use
- Blotting, Western
- Carcinoma, Endometrioid -- drug therapy
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Chemotherapy, Adjuvant
- DNA Topoisomerases, Type II -- metabolism
- DNA-Binding Proteins -- metabolism
- Endometrial Neoplasms -- drug therapy
- Female
- Humans
- Hypoglycemic Agents -- therapeutic use
- Immunohistochemistry
- Ki-67 Antigen -- metabolism
- MAP Kinase Signaling System
- Metformin -- therapeutic use
- Middle Aged
- Mitogen-Activated Protein Kinase 1 -- metabolism
- Mitogen-Activated Protein Kinase Kinases -- metabolism
- Neoadjuvant Therapy -- methods
- Neoplasm Grading
- Neoplasm Staging
- Proliferating Cell Nuclear Antigen -- metabolism
- Prospective Studies
- Ribosomal Protein S6 -- metabolism
- TOR Serine-Threonine Kinases -- metabolism
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.